Kemi is an advisor to private equity firms, strategic investors, lenders, C-Suite executives and owner-operators on the financial aspects of mergers and acquisitions (M&A) in the healthcare industry. She provides a range of advisory services which offer deep financial and strategic insights that support enterprise valuation and guide investment decisions and risk assessments.

Kemi has led both buy-side and sell-side financial due diligence engagements across various provider types in the addiction treatment/substance use disorder (SUD), mental health, autism and intellectual and developmental disabilities segments. Additionally, Kemi's transaction experience includes primary care and specialty care physician practices, diagnostic imaging centers, laboratory services, urgent care facilities, ambulatory surgery centers, home health, home care and hospice agencies, medical technology distributors, pharmacies, and healthcare-related management services.